Episodic Migraine
Episodic migraine is a type of headache disorder that causes recurrent, severe headaches often accompanied by nausea, vomiting, and sensitivity to light and sound. These headaches can last from a few hours to several days.
Cabergoline for Episodic Migraine Relief
We are studying whether cabergoline can help reduce the frequency and severity of migraines in people with episodic migraine. Participants will receive either cabergoline or a placebo to compare effects.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you at least 18 years old?
- Do you have episodic migraines (less than 15 headache days per month) for at least the last 12 months?
- Have you had between 4 and 14 migraine days in the last 3 months?
- Are you currently pregnant or breastfeeding?
- Are you willing to use a reliable method of contraception if you are a woman of child-bearing potential or if your partner is?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Actualene
Cabaser
Cabaseril
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Region Midtjylland
Department of Endocrinology and Internal Medicine
Århus, Denmark
Sponsor: Aarhus Universitet
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.